Prognostic role of nuclear factor/IB and bone remodeling proteins in metastatic giant cell tumor of bone: A retrospective study

Publisher： John Wiley & Sons Inc

E-ISSN： 1554-527x|33|8|1205-1211

ISSN： 0736-0266

Source： JOURNAL OF ORTHOPAEDIC RESEARCH, Vol.33, Iss.8, 2015-08, pp. : 1205-1211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

p63 as a prognostic marker for giant cell tumor of bone

By Yanagisawa Michiro  

Upsala Journal of Medical Sciences, Vol. 118, Iss. 1, 2013-03 ,pp. : 23-28

Informa Healthcare

Access to resources Recommend Favorite

Giant cell tumor of bone revisited

By Mavrogenis Andreas F.   Igoumenou Vasileios G.   Megaloikonomos Panayiotis D.   Panagopoulos Georgios N.   Papagelopoulos Panayiotis J.   Soucacos Panayotis N.  

Sicot-J, Vol. 3, Iss. issue, 2017-09 ,pp. : 54-54

Edp Sciences

Access to resources Recommend Favorite

Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumor of bone

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 6, 2015-06 ,pp. : 1078-1080

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transcrestal Sinus Lift Using Platelet Concentrates in Association to Short Implant Placement: A Retrospective Study of Augmented Bone Height Remodeling

By  

CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH, Vol. 18, Iss. 5, 2016-10 ,pp. : 993-1002

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum osteoprotegerin and receptor activator of nuclear factor-κB ligand (RANKL) concentrations in allogeneic stem cell transplant-recipients: a role in bone loss?

By Kananen K.   Volin L.   Laitinen K.   Ruutu T.   Välimäki M.  

Osteoporosis International, Vol. 17, Iss. 5, 2006-05 ,pp. : 724-730

Springer Publishing Company

Access to resources Recommend Favorite